Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Cyclotron Systems (ACSI) is a premier manufacturer of high-capacity cyclotron systems used for the production of medical radioisotopes. The company specializes in the design and installation of TR-series cyclotrons, which are utilized globally for PET and SPECT imaging in oncology, cardiology, and neurology. Their product line includes the TR-19, TR-24, and TR-30 models, capable of producing a wide range of isotopes such as Fluorine-18, Carbon-11, and Technetium-99m. ACSI provides end-to-end solutions, including facility design, shielding, and long-term technical support for hospitals and radiopharmaceutical production centers. By advancing particle accelerator technology, the company plays a critical role in the supply chain for diagnostic and therapeutic nuclear medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Cyclotron Systems.